Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q1)Jun 30, 2025 | (FY)Mar 31, 2025 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 4.79%26.63B | 4.40%109.21B | 4.43%25.41B | 15.40%104.6B | 15.38%25.16B | 11.85%27.77B | 18.34%27.33B | 16.39%24.33B | 23.16%90.64B | 6.89%21.81B |
| Cost of revenue | 2.10%22.19B | 3.86%91.94B | 4.65%21.74B | 14.07%88.52B | 18.21%21.23B | 8.81%23.53B | 14.51%23B | 15.78%20.77B | 26.13%77.61B | 3.82%17.96B |
| Gross profit | 20.69%4.43B | 7.38%17.26B | 3.17%3.67B | 23.31%16.08B | 2.16%3.93B | 32.38%4.25B | 43.86%4.34B | 20.06%3.56B | 8.05%13.04B | 23.97%3.85B |
| Operating expense | 7.82%2.07B | 8.58%8.4B | 5.33%1.92B | 3.87%7.74B | -4.22%1.81B | 6.80%2.09B | 7.03%2.01B | 6.00%1.82B | 3.46%7.45B | 1.12%1.89B |
| Staff costs | 1.91%1.02B | 5.61%4.18B | 5.06%997M | 3.24%3.96B | 5.03%1B | 2.02%1.01B | 1.95%994M | 4.06%949M | 8.86%3.83B | 4.83%955M |
| Selling and administrative expenses | 10.87%306M | 10.37%2.32B | 6.56%276M | 10.98%2.1B | 4.77%1.16B | 35.04%370M | 13.50%311M | 9.28%259M | -0.73%1.9B | -4.15%1.11B |
| -General and administrative expense | 10.87%306M | 10.37%2.32B | 6.56%276M | 10.98%2.1B | 4.77%1.16B | 35.04%370M | 13.50%311M | 9.28%259M | -0.73%1.9B | -4.15%1.11B |
| Depreciation and amortization | -3.19%91M | -5.31%392M | -7.84%94M | -2.59%414M | 3.23%96M | -7.76%107M | -3.54%109M | -0.97%102M | -2.52%425M | -15.45%93M |
| -Depreciation | -3.19%91M | -5.31%392M | -7.84%94M | -2.59%414M | 3.23%96M | -7.76%107M | -3.54%109M | -0.97%102M | -2.52%425M | -15.45%93M |
| Other operating expenses | 18.91%654M | 19.49%1.51B | 7.84%550M | -2.55%1.26B | -69.70%-448M | 4.51%603M | 15.47%597M | 9.68%510M | -2.85%1.3B | 13.73%-264M |
| Operating profit | 34.72%2.37B | 6.27%8.86B | 0.92%1.76B | 49.21%8.34B | 8.34%2.12B | 72.36%2.16B | 104.85%2.33B | 39.39%1.74B | 14.83%5.59B | 58.73%1.95B |
| Net non-operating interest income (expenses) | 35.00%81M | 58.54%325M | 42.86%60M | 37.58%205M | 54.29%54M | 75.76%58M | 6.25%51M | 27.27%42M | 12.88%149M | 9.38%35M |
| Non-operating interest income | 32.26%82M | 55.14%332M | 44.19%62M | 39.87%214M | 63.89%59M | 73.53%59M | 8.16%53M | 26.47%43M | 12.50%153M | 9.09%36M |
| Non-operating interest expense | -50.00%1M | -22.22%7M | 100.00%2M | 125.00%9M | 400.00%5M | 0.00%1M | 100.00%2M | 0.00%1M | 0.00%4M | 0.00%1M |
| Net investment income | 197.89%283M | -710.00%-162M | 4,650.00%95M | -112.90%-20M | 20.83%-76M | -61.67%46M | -89.47%8M | -96.36%2M | 11.51%155M | -220.00%-96M |
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | 0 | -68.67%47M | 370.00%47M | -22.68%150M | 0 | -27.84%140M | 0 | 10M | -28.94%194M | 0 |
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | -33.33%2M | -423.33%-97M | 118.75%3M | -97.62%30M | -101.97%-7M | -320.00%-21M | 3,600.00%74M | -101.76%-16M | 18,114.29%1.26B | 17,700.00%356M |
| Less:Restructuring and mergern&acquisition | ---- | ---- | ---- | --0 | --0 | ---- | ---- | --0 | ---921M | --0 |
| Less:Other special charges | 33.33%-2M | 423.33%97M | -118.75%-3M | 91.18%-30M | 101.97%7M | 320.00%21M | -3,600.00%-74M | 23.08%16M | -4,957.14%-340M | -17,700.00%-356M |
| Other non-operating income (expenses) | -34.55%180M | 11.24%881M | 12.70%275M | 49.15%792M | -4.52%190M | 33.06%165M | 89.22%193M | 130.19%244M | -9.23%531M | -28.16%199M |
| Income before tax | 29.96%2.91B | 3.80%9.86B | 10.80%2.24B | 20.58%9.5B | -6.63%2.28B | 47.82%2.54B | 94.57%2.65B | -14.02%2.02B | 31.49%7.88B | 61.64%2.44B |
| Income tax | 26.15%743M | 12.18%2.94B | -2.81%589M | 73.40%2.62B | 96.43%660M | 36.23%628M | 102.79%726M | 70.22%606M | 1.55%1.51B | -10.88%336M |
| Net income | 31.27%2.16B | 0.63%6.92B | 16.64%1.65B | 8.03%6.88B | -23.14%1.62B | 52.26%1.92B | 91.35%1.93B | -29.05%1.41B | 41.42%6.36B | 85.81%2.11B |
| Net income continuous operations | 31.33%2.16B | 0.61%6.92B | 16.64%1.65B | 8.05%6.88B | -23.06%1.62B | 52.06%1.92B | 91.64%1.93B | -29.08%1.41B | 41.39%6.36B | 85.73%2.11B |
| Noncontrolling interests | 28.64%256M | -1.42%974M | -15.68%199M | -0.60%988M | -30.61%238M | 26.03%276M | 31.49%238M | -5.98%236M | 56.78%994M | 78.65%343M |
| Net income attributable to the company | 31.72%1.91B | 0.95%5.94B | 23.15%1.45B | 9.63%5.89B | -21.69%1.38B | 57.64%1.64B | 104.85%1.69B | -32.43%1.18B | 38.94%5.37B | 87.27%1.77B |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 31.72%1.91B | 0.95%5.94B | 23.15%1.45B | 9.63%5.89B | -21.69%1.38B | 57.64%1.64B | 104.85%1.69B | -32.43%1.18B | 38.94%5.37B | 87.27%1.77B |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 31.57%164.67 | 4.03%513.64 | 29.46%125.16 | 12.80%493.73 | -18.00%118.72 | 62.24%139.27 | 108.58%139.06 | -31.14%96.68 | 41.57%437.69 | 90.25%144.78 |
| Diluted earnings per share | 31.57%164.67 | 4.03%513.64 | 29.46%125.16 | 12.80%493.73 | -18.00%118.72 | 62.65%139.27 | 108.58%139.06 | -31.14%96.68 | 41.57%437.69 | 90.25%144.78 |
| Dividend per share | 0 | 31.25%210 | 0 | 128.57%160 | 125.00%90 | 0 | 133.33%70 | 0 | 27.27%70 | 33.33%40 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |